admin

In this article NVO NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Novo Nordisk CEO Lars Fruergaard Jørgensen on Friday said the company’s experimental weight loss pill, amycretin, could eventually become a best-in-class treatment for obesity.  The Danish drugmaker is racing to capitalize on the runaway success of its blockbuster weight loss drug Wegovy by developing
0 Comments
Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters The Food and Drug Administration approved Novo Nordisk‘s blockbuster weight loss drug Wegovy for use in slashing the risk of serious cardiovascular complications in people with obesity and heart disease, the
0 Comments
10’000 Hours | Digitalvision | Getty Images In an increasingly digital world, the specter of financial fraud looms large, especially for older adults. My experience with an 81-year-old client offers a stark illustration. While assisting “Emma” (not her real name) with email issues, I witnessed her vulnerability to scams firsthand. Despite my repeated warnings over
0 Comments
CostFoto | Future Publishing | Getty Images New York Community Bank has lost 7% of deposits over a turbulent month as customers pulled their money from the regional commercial bank. A new capital infusion of over $1 billion takes the NYCB off the “watch list” for another potential bank failure, according to Sheila Bair, former
0 Comments
Shares of Teleperformance plunged 20% on Thursday, after the French call center and office services group missed its full-year revenue target and flagged a “volatile economic environment.” Investors have been spooked by the potential impact of artificial intelligence on its business model, as companies become more able to tap into the technology directly for their
0 Comments